Immunochemotherapy for Bcl-2 and MUM-negative aggressive primary cutaneous B-cell non-Hodgkin’s lymphoma

被引:0
|
作者
Natasa Colovic
Vladimir Jurisic
Tatjana Terzic
Henry Dushan Atkinson
Milica Colovic
机构
[1] Institute of Hematology Clinical Center Serbia,Imperial College School of Medicine
[2] Institute for Pathology,undefined
[3] St Mary’s Hospital,undefined
来源
Archives of Dermatological Research | 2009年 / 301卷
关键词
Cutaneous B-cell non-Hodgkin’s lymphoma; Scalp; High grade; Follicle center lymphoma; Immunohistochemistry; Immunochemotherapy; Rituximab;
D O I
暂无
中图分类号
学科分类号
摘要
The case of a 44-year-old man with a primary cutaneous large B-cell non-Hodgkin’s lymphoma of the scalp is reported. His mother died of gastric lymphoma and his sib brother is in a 20-year remission of T-cell lymphoma. The patient presented with a 16-year history of occipital and parietal alopecia and a recently worsening scalp rash. The histopathology and immunohistochemistry performed in April 2006 indicated a bcl-6+, MUM− and bcl-2−, primary cutaneous follicle center B-cell non-Hodgkin’s lymphoma, with an aggressive transformation to a diffuse large B-cell lymphoma. Bone marrow biopsy and CT chest, abdomen, and pelvis were negative for systemic lymphoma. The patient had an excellent clinical and histological resolution following 8 cycles of rituximab and CHOP protocol immunochemotherapy, and remains in complete remission until now. The protracted indolent phase of the disease, the familial history of lymphoma, the histological aggressive features and the patient’s excellent response to immunochemotherapy all contribute to a very unusual manifestation of this disease.
引用
收藏
页码:689 / 692
页数:3
相关论文
共 50 条
  • [31] A comprehensive review of lenalidomide therapy for B-cell non-Hodgkin lymphoma
    Witzig, T. E.
    Nowakowski, G. S.
    Habermann, T. M.
    Goy, A.
    Hernandez-Ilizaliturri, F. J.
    Chiappella, A.
    Vitolo, U.
    Fowler, N.
    Czuczman, M. S.
    ANNALS OF ONCOLOGY, 2015, 26 (08) : 1667 - 1677
  • [32] Clinical experience with biweekly CHOP plus rituximab chemoimmunotherapy for the treatment of aggressive B-cell non-Hodgkin lymphoma
    David Aguiar Bujanda
    José Aguiar Morales
    Uriel Bohn Sarmiento
    Salvador Saura Grau
    Carlos Rodríguez Franco
    Clinical and Translational Oncology, 2009, 11 : 604 - 608
  • [33] Clinical experience with biweekly CHOP plus rituximab chemoimmunotherapy for the treatment of aggressive B-cell non-Hodgkin lymphoma
    Aguiar Bujanda, David
    Aguiar Morales, Jose
    Bohn Sarmiento, Uriel
    Saura Grau, Salvador
    Rodriguez Franco, Carlos
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2009, 11 (09) : 604 - 608
  • [34] Current Opinion on Pixantrone in the Treatment of Non-Hodgkin B-Cell Lymphoma
    Novakovic, Barbara Jezersek
    Boltezar, Lucka
    Novakovic, Aleksander
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2021, 17 : 183 - 192
  • [35] Antibody-drug conjugates for the treatment of B-cell non-Hodgkin's lymphoma and leukemia
    Chu, Yu-Waye
    Polson, Andrew
    FUTURE ONCOLOGY, 2013, 9 (03) : 355 - 368
  • [36] BCL-6 expression in reactive lymphoid tissue and in B-cell non-Hodgkin's lymphomas
    Pittaluga, S
    Ayoubi, TAY
    Wlodarska, I
    Stul, M
    Cassiman, JJ
    Mecucci, C
    VanDenBerghe, H
    VanDeVen, WJM
    DeWolfPeeters, C
    JOURNAL OF PATHOLOGY, 1996, 179 (02) : 145 - 150
  • [37] Interstitial Pneumonia After Autologous Hematopoietic Stem Cell Transplantation in B-Cell Non-Hodgkin Lymphoma
    Kato, Harumi
    Yamamoto, Kazuhito
    Taji, Hirofumi
    Oki, Yasuhiro
    Chihara, Dai
    Seto, Masao
    Kagami, Yoshitoyo
    Morishima, Yasuo
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2011, 11 (06) : 483 - 489
  • [38] The place of allogeneic stem cell transplantation in aggressive B-cell non-Hodgkin lymphoma in the era of CAR-T-cell therapy
    Castagna, Luca
    Bono, Roberto
    Tringali, Stefania
    Sapienza, Giuseppe
    Santoro, Alessandra
    Indovina, Alessandro
    Tarantino, Vittoria
    Di Noto, Laura
    Maggio, Aurelio
    Patti, Caterina
    FRONTIERS IN MEDICINE, 2022, 9
  • [39] The unexpected evolution of a case of diffuse large B-cell non-Hodgkin lymphoma
    Gaman, Amelia
    Bold, Adriana
    Gaman, G.
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2011, 52 (02) : 719 - 722
  • [40] Evaluation of Significance of Lymphocyte Subpopulations and Non-specific Serologic Markers in B-cell Non-Hodgkin's Lymphoma Patients
    Posfai, Eva
    Irsai, Gabor
    Illes, Arpad
    Mehes, Gabor
    Marton, Imelda
    Molnar, Csaba
    Csipo, Istvan
    Barath, Sandor
    Gergely, Lajos
    PATHOLOGY & ONCOLOGY RESEARCH, 2014, 20 (03) : 649 - 654